The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis.

Abstract

Sepsis represents a major global health burden. Early diagnosis of sepsis as well as guiding early therapeutic decisions in septic patients still represent major clinical challenges. In this context, a whole plethora of different clinical and serum-based markers have been tested regarding their potential for early detection of sepsis and their ability to stratify patients according to their probability to survive critical illness and sepsis. Adipokines represent a fast-growing class of proteins that have gained an increasing interest with respect to their potential to modulate immune responses in inflammatory and infectious diseases. We review current knowledge on the role of different adipokines in diagnostic work-up and risk stratification of sepsis as well as critical illness. We discuss recent data from animal models as well as from clinical studies and finally highlight the limitations of these analyses that currently prevent the use of adipokines as biomarkers in daily practice.

• Authors: Sven H Loosen, Alexander Koch, Frank Tacke, Christoph Roderburg, Tom Luedde
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 20 Issue 19 (Sep 28 2019) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 31569348 (Publication Type: Journal Article, Review)

Chemical References

• Adipokines
• Biomarkers

Topics

• Adipokines (blood)
• Animals
• Biomarkers
• Case-Control Studies
• Critical Illness
• Early Diagnosis
• Humans
• Prognosis
• Sepsis (blood, diagnosis)